$47.27
-2.16 (-4.37%)
At Close: Jul 31, 2026
Could 10x Genomics Deliver a 10x Return?
06:04am, Monday, 05'th Apr 2021
The company's CEO thinks it's capitalizing on the biggest value-creation opportunity of the next several decades.
How Can Investors Find Innovative Companies Early?
11:01am, Sunday, 04'th Apr 2021
10x Genomics' CEO identifies three key things to look for.
10x Genomics CEO: Why We're at the Beginning of a Biology Revolution
07:03am, Sunday, 04'th Apr 2021
Several trends are converging.
10x Genomics Puts Single Cell Analysis Within Reach of All With Low Throughput Gene Expression Kit
08:30am, Thursday, 01'st Apr 2021
Along with recent release of CellPlex, product increases access through affordability Along with recent release of CellPlex, product increases access through affordability
Analysts See Plenty of Potential for 10x Genomics
11:24am, Friday, 26'th Mar 2021
Eighteen months after going public, 10x Genomics Inc.'s (TGX) shares have tripled to more than $166, yet analysts think that's still well below its twelve-month median price target. Some on Wall Stree
Conoco, Dow, Pure Storage, Signet Jewelers and More of Monday Afternoon's Analyst Calls
11:53am, Monday, 15'th Mar 2021
With the trading day nearing halfway over, the broad markets were trading sideways on Monday.
10x Genomics Expands Pleasanton Headquarters with New Facilities at Two Locations
08:30am, Tuesday, 09'th Mar 2021
City to Change Street Name to ‘Genomics Place'
OMX Ventures Adds New Team Members to Expand Investment and Company Creation Activities in $150M Oversubscribed Fund I
08:02am, Tuesday, 02'nd Mar 2021
CHICAGO--(BUSINESS WIRE)--OMX Ventures expands team with addition of Jamie Kasuboski, Ph.D. as Vice President and Kevin Ness, Ph.D. as Fund Advisor.
Baron Perspective- 2020: A Year We Will Remember
06:19pm, Monday, 01'st Mar 2021
2020 was a year that will be hard to forget. The headlines were dominated by the pandemic and its social and economic aftermath, but there were also wildfires, violent social and racial unrest, the U.
10x Genomics to Present at the 41st Annual Cowen Health Care Conference
08:05am, Thursday, 25'th Feb 2021
PLEASANTON, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) -- 10x Genomics, Inc. (Nasdaq: TXG), today announced the company will be participating in the upcoming 41st Annual Cowen Health Care Conference.
10x Genomics Showcases Next Wave of Innovations at First Ever Xperience Event
04:05pm, Wednesday, 24'th Feb 2021
Acquires Tetramer Shop; Reveals Details on Upcoming Products Acquires Tetramer Shop; Reveals Details on Upcoming Products
Why 10x Genomics' Soaring Q4 Revenue Wasn't Enough to Impress Investors
06:00am, Thursday, 18'th Feb 2021
The problem was the company's worsening bottom line.
10x Genomics, Inc. (TXG) CEO Serge Saxonov on Q4 2020 Results - Earnings Call Transcript
08:24pm, Wednesday, 17'th Feb 2021
10x Genomics, Inc. (TXG) CEO Serge Saxonov on Q4 2020 Results - Earnings Call Transcript
10x Genomics to Report Fourth Quarter and Full Year 2020 Financial Results on February 17, 2021
04:10pm, Thursday, 28'th Jan 2021
PLEASANTON, Calif., Jan. 28, 2021 (GLOBE NEWSWIRE) -- 10x Genomics (Nasdaq: TXG) today announced it will report financial results for the fourth quarter and full year ended December 31, 2020 after mar
10X Genomics Strategy Driven By Innovation, CEO Says
03:29pm, Tuesday, 12'th Jan 2021
Jan.12 -- 10X Genomics Inc. Chief Executive Officer Serge Saxonov discusses the company's strategy and performance amid the Covid-19 pandemic with Bloomberg's Vonnie Quinn on "Bloomberg Markets."
Sign In
Buy TXG